Skip to main content
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 2001 Nov-Dec;7(6):1043–1045. doi: 10.3201/eid0706.010624

Catheter-related bacteremia due to Streptomyces in a patient receiving holistic infusions.

J Carey 1, M Motyl 1, D C Perlman 1
PMCID: PMC2631926  PMID: 11747739

Abstract

Streptomyces species are rare causes of invasive infection in humans. We report the first documented case of a catheter-associated bacteremia due to Streptomyces. The most likely source of infection was unlicensed, injectable holistic preparations that the patient had received. We review reported cases of invasive infections caused by Streptomyces and comment on the potential infectious complications of parenteral holistic treatments.

Full Text

The Full Text of this article is available as a PDF (20.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angell M., Kassirer J. P. Alternative medicine--the risks of untested and unregulated remedies. N Engl J Med. 1998 Sep 17;339(12):839–841. doi: 10.1056/NEJM199809173391210. [DOI] [PubMed] [Google Scholar]
  2. Arbab M. A., el Hag I. A., Abdul Gadir A. F., Siddik H el-R Intraspinal mycetoma: report of two cases. Am J Trop Med Hyg. 1997 Jan;56(1):27–29. doi: 10.4269/ajtmh.1997.56.27. [DOI] [PubMed] [Google Scholar]
  3. Bauer B. A. Herbal therapy: what a clinician needs to know to counsel patients effectively. Mayo Clin Proc. 2000 Aug;75(8):835–841. doi: 10.4065/75.8.835. [DOI] [PubMed] [Google Scholar]
  4. Dunne E. F., Burman W. J., Wilson M. L. Streptomyces pneumonia in a patient with human immunodeficiency virus infection: case report and review of the literature on invasive streptomyces infections. Clin Infect Dis. 1998 Jul;27(1):93–96. doi: 10.1086/514612. [DOI] [PubMed] [Google Scholar]
  5. Galil K., Miller L. A., Yakrus M. A., Wallace R. J., Jr, Mosley D. G., England B., Huitt G., McNeil M. M., Perkins B. A. Abscesses due to mycobacterium abscessus linked to injection of unapproved alternative medication. Emerg Infect Dis. 1999 Sep-Oct;5(5):681–687. doi: 10.3201/eid0505.990509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Martin G. J., Blazes D. L., Mayers D. L., Spooner K. M. Stavudine-induced macrocytosis during therapy for human immunodeficiency virus infection. Clin Infect Dis. 1999 Aug;29(2):459–460. doi: 10.1086/520245. [DOI] [PubMed] [Google Scholar]
  7. McNeil M. M., Brown J. M., Jarvis W. R., Ajello L. Comparison of species distribution and antimicrobial susceptibility of aerobic actinomycetes from clinical specimens. Rev Infect Dis. 1990 Sep-Oct;12(5):778–783. doi: 10.1093/clinids/12.5.778. [DOI] [PubMed] [Google Scholar]
  8. McNeil M. M., Brown J. M. The medically important aerobic actinomycetes: epidemiology and microbiology. Clin Microbiol Rev. 1994 Jul;7(3):357–417. doi: 10.1128/cmr.7.3.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Piscitelli S. C., Burstein A. H., Chaitt D., Alfaro R. M., Falloon J. Indinavir concentrations and St John's wort. Lancet. 2000 Feb 12;355(9203):547–548. doi: 10.1016/S0140-6736(99)05712-8. [DOI] [PubMed] [Google Scholar]
  10. Ruschitzka F., Meier P. J., Turina M., Lüscher T. F., Noll G. Acute heart transplant rejection due to Saint John's wort. Lancet. 2000 Feb 12;355(9203):548–549. doi: 10.1016/S0140-6736(99)05467-7. [DOI] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES